STORY FROM: Drugs & Medical Devices
DePuy, J&J Move for JNOV Following $247 Million Pinnacle Hip Verdict
September 27, 2018
DALLAS — DePuy Orthopaedics Inc. and its parent Johnson & Johnson have moved for judgment notwithstanding the verdict following a Pinnacle Ultamet hip trial that ended in verdicts totaling $246,998,791.22, arguing the evidence did not support the jury’s findings.
In Sept. 26 motion filed before Judge Ed Kinkeade of the U.S. District Court for the Northern District of Texas, the defendants argued that plaintiffs failed to present evidence supporting their claims of design defect, failure-to-warn, fraud and punitive damages.
The Pinnacle metal-on-metal device was used to replace diseased hip joints and was intended to provide pain-free natural motion over a ...
Associated Law Firms
Fisher Boyd Johnson & Huguenard
King & Spalding
Neblett Beard & Arsenault
Quattlebaum Grooms & Tull
Simmons Hanly Conroy
Skadden Arps Slate Meagher & Flom
The Lanier Law Firm
Defective Design Motion
Punitive Damages Motion